| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.247 | 15.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 20.247 | 15.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 231 | 130 | 1.151 | 0 | 0 | 0 | 47.380 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 20.017 | 14.900 | -1.151 | 0 | 0 | 0 | -47.380 | 0 | 0 | - |
| Net Profit/Loss - EUR | 19.409 | 14.449 | -1.151 | 0 | 0 | 0 | -47.380 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Falvet Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 57.353 | 67.215 | 62.899 | 61.744 | 60.549 | 59.401 | 10.704 | 10.737 | 10.704 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 46.443 | 55.420 | 51.308 | 50.366 | 49.391 | 48.454 | 0 | 0 | 0 | - |
| Cash | 10.910 | 11.795 | 11.591 | 11.378 | 11.158 | 10.946 | 10.704 | 10.737 | 10.704 | - |
| Shareholders Funds | 32.917 | 42.577 | 38.678 | 57.056 | 55.951 | 54.890 | 6.293 | 6.312 | 6.293 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 24.436 | 24.638 | 24.221 | 4.689 | 4.598 | 4.511 | 4.411 | 4.425 | 4.411 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Falvet Med Srl